Is liver biopsy necessary in the management of alcoholic hepatitis?

World Journal of Gastroenterology

Volumn 19, Issue 44, 2013, Pages 7825-7829

  Dhanda, Ashwin D ^a,b   Collins, Peter L ^a   McCune, C Anne ^a  

^a UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alcoholic hepatitis; Diagnosis; Liver biopsy; Prognosis; Transjugular liver biopsy

Indexed keywords

BILIRUBIN; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; CHRONIC LIVER FAILURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EDITORIAL; HUMAN; JAUNDICE; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER CELL DAMAGE; NEUTROPHIL CHEMOTAXIS; RISK FACTOR; SCORING SYSTEM; SEPSIS;

ALCOHOLIC HEPATITIS; DIAGNOSIS; LIVER BIOPSY; PROGNOSIS; TRANSJUGULAR LIVER BIOPSY;

ACUTE DISEASE; BIOPSY; DIAGNOSIS, DIFFERENTIAL; HEPATITIS, ALCOHOLIC; HUMANS; LIVER; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84888608754     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i44.7825     Document Type: Editorial

References (35)

1. Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011; 60: 255-260 [PMID: 20940288 DOI: 10.1136/gut.2010.224097]
2. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769 [PMID: 19553649]
3. Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol 2012; 56 Suppl 1: S39-S45 [PMID: 22300464 DOI: 10.1016/S0168-8278(12)60005-1]
4. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 221-232 [PMID: 3022386 DOI: 10.1055/s-2008-1040605]
5. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1981; 1: 707-711 [PMID: 6110925]
6. European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J epatol 2012; 57: 399-420 [PMID: 22633836]
7. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology 2010; 51: 307-328 [PMID: 20034030 DOI:10.1002/hep.23258]
8. Jamal MM, Morgan TR. Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol 2003; 17: 649-662 [PMID: 12828960 DOI: 10.1016/S1521-6918(03)00018-0]
9. Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R, Arroyo V, Caballería J, Ginès P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008; 103: 2747-2756 [PMID: 18721242]
10. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, Benhamou JP, Chaput JC, Rueff B, Poynard T. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996; 110: 1847-1853 [PMID: 8964410 DOI: 10.1053/gast.1996. v110.pm8964410]
11. Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, Garcia-Tsao G, Kamath PS. Intensive care of the patient with cirrhosis. Hepatology 2011; 54: 1864-1872 [PMID: 21898477]
12. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. Acuteon-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-282 [PMID: 19669378 DOI: 10.1007/ s12072-008-9106-x]
13. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-1437, 1437.e1-9 [PMID: 23474284 DOI: 10.1053/j.gastro.2013.02.042]
14. Mookerjee RP, Lackner C, Stauber R, Stadlbauer V, Deheragoda M, Aigelsreiter A, Jalan R. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol 2011; 55: 1103-1111 [PMID: 21376092 DOI: 10.1016/j.jhep.2011.02.021]
15. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, Roskams T, Nevens F. Early features of acute-onchronic alcoholic liver failure: a prospective cohort study. Gut 2010; 59: 1561-1569 [PMID: 20675694 DOI: 10.1136/ gut.2009.189639]
16. Elphick DA, Dube AK, McFarlane E, Jones J, Gleeson D. Spectrum of liver histology in presumed decompensated alcoholic liver disease. Am J Gastroenterol 2007; 102: 780-788 [PMID: 17222323]
17. Wells JT, Said A, Agni R, Tome S, Hughes S, Dureja P, Lucey MR. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation. Liver Transpl 2007; 13: 1728-1735 [PMID: 18044757 DOI:10.1002/lt.21298]
18. Tomé S, Martinez-Rey C, González-Quintela A, Gude F, Brage A, Otero E, Abdulkader I, Forteza J, Bustamante M, Varo E. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol 2002; 36: 793-798 [PMID: 12044530DOI:10.1016/S0168-8278(02)00047-8]
19. Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982; 83: 338-340 [PMID: 7084612]
20. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009; 49: 1017-1044 [PMID: 19243014 DOI: 10.1002/hep.22742]
21. Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, Patch D, Burroughs AK. Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. J Hepatol 2007; 47: 284-294 [PMID: 17561303 DOI: 10.1016/ j.jhep.2007.05.001]
22. Spahr L, Rubbia-Brandt L, Genevay M, Hadengue A, Giostra E. Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterol 2011; 11: 115 [PMID: 22035247 DOI: 10.1186/14 71-230X-11-115]
23. Bedossa P, Poynard T, Naveau S, Martin ED, Agostini H, Chaput JC. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988; 12: 173-178 [PMID: 3279852 DOI: 10.1111/j.1530-0277.1988. tb00155.x]
24. Duvoux C, Radier C, Roudot-Thoraval F, Maille F, Anglade MC, Van Nhieu JT, Rosa I, Hospitel S, Abd-Alsamad I, Sitruk V, Seror O, Ziol M, Blondon H, Dhumeaux D, Richardet JP. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis. Hepatology 2004; 40: 1370-1378 [PMID: 15565651 DOI:10.1002/hep.20475]
25. Dominguez M, Miquel R, Colmenero J, Moreno M, García-Pagán JC, Bosch J, Arroyo V, Ginès P, Caballería J, Bataller R. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009; 136: 1639-1650 [PMID: 19208360 DOI:10.1053/j.gastro.2009.01.056]
26. Maltby J, Wright S, Bird G, Sheron N. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 1996; 24: 1156-1160 [PMID: 8903391 DOI: 10.1053/ jhep.1996.v24.pm0008903391]
27. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-46 [PMID: 8325620]
28. Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut 1992; 33: 268-271 [PMID: 1347281 DOI: 10.1136/gut.33.2.268]
29. Degré D, Lemmers A, Gustot T, Ouziel R, Trépo E, Demetter P, Verset L, Quertinmont E, Vercruysse V, Le Moine O, Devière J, Moreno C. Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clin Exp Immunol 2012; 169: 302-310 [PMID: 22861370 DOI: 10.1111/j.1365-2249.2012.04609.x]
30. Altamirano J, Miqquel R, Katoonizadeh A, Duarte-Rojo A, Smyrk TC, Michelena J, Garcia-Pagan JC, Arroyo V, Gines P, Caballeria J, Roskams T, Shah V, Bataller R. Development and validation of a novel histological classification with prognostic value. Hepatology 2011; 54: A968
31. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199 [PMID: 352788]
32. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54: 1174-1179 [PMID: 16009691 DOI: 10.1136/ gut.2004.050781]
33. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45: 1348-1354 [PMID: 17518367 DOI:10.1002/hep.21607]
34. Hamid R, Forrest EH. Is histology required for the diagnosis of alcoholic hepatitis? A review of published randomised controlled trials. Gut 2011; 60 (Suppl 1): A233 [DOI: 10.1136/gut.2011.239301.492]
35. Mathurin P, Poynard T, Ramond MJ, Degolt C. Interet de la biopsie hepatique pour la selection des sujets suspects d' hepatitealcoolique aigue. Gastroenterol Clin Biol 1992; 16: A231